|
Prous Institute for Biomedical Research presented at the 20th International Symposium on Medicinal Chemistry organized by European Federation of Medicinal Chemistry (EFMC), the 2008 Prous Institute – Overton & Meyer Award, that recognizes outstanding contributions to the development of new technologies in the field of medicinal chemistry, to Professor Steven V. Ley.
This award acknowledges Professor Ley’s commitment to the development, discovery, evaluation and use of new technologies for drug discovery. Through his career, Prof. Ley has been interested in how technology can impact on synthetic chemistry attaining excellent results in many key areas of technology in drug discovery. His contributions include early adoption of ultrasound and microwave techniques for chemical synthesis, the use of experimental software for reaction optimization, the multi-step use of immobilised reagents, scavengers and catch and release concepts, the generation of encapsulated catalysts for cleaner reaction processing, the use of immobilised enzymes in synthesis, and the impressive advances in the area of flow chemistry and micro reactor technology. The brilliant results achieved by Prof. Ley, documented in over 630 publications in the area of new synthetic methods and their application to biologically active molecules, give him a great visibility in the field of medicinal chemistry and drug discovery.
About Prous Institute - Overton & Meyer Award for New Technologies in Drug Discovery
The "Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery" was established to encourage innovation and investigation in technologies related to drug discovery. The Award is given biennially to acknowledge the discovery, evaluation or use of a new technology.
About Prous Institute for Biomedical Research
Prous Institute is a privately-held research-driven organization committed to the discovery and development of innovative therapies through the use of its powerful computational tools and the support of basic research. Prous Institute also fosters the development of prediction technologies used for regulatory and industry safety screening programs. Prous Institute receives several government grants and actively collaborates with academia and industry. Prous Institute is currently evaluating international research opportunities in Boston, Tokyo and Shanghai.
|